Intriguingly, MOLM-13 and MV-4-11 AML cell lines carrying TP53wt and concurrent FLT3-ITDmut mutations were the most sensitive to APG-115-induced growth inhibition, compared to non-FLT3-mutated OCI-AML-3 cells. Here, FLT3 is linked to acute myeloid leukemia.